» Articles » PMID: 29172275

Interleukin-6 Genetic Variation and Susceptibility to Gastric Cancer in an Iranian Population

Overview
Specialty Oncology
Date 2017 Nov 28
PMID 29172275
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite recent decrease in the incidence of gastric cancer, it is still a common type of cancer in the north of Iran. Many evaluations have shown that polymorphisms of cytokine genes like that for interleukin 6 (IL-6), which play important roles in regulation of the immune response, can increase the risk of gastric cancer. This study examined the role of the IL-6-174 gene polymorphism in susceptibility in an Iranian population. Method: Genomic DNA was extracted from peripheral whole blood of 100 patients and 361 healthy controls. Genotyping was accomplished by the sequence-specific primer-polymerase chain reaction (SSP-PCR) method and statistical analyses were carried out using Fisher’s exact test. Frequencies of the IL-6-174 G/C genotypes were determined under co-dominant, dominant, and recessive genetic models. Results: An association between the polymorphism of IL-6 -174 G/C and susceptibility to gastric cancer was observed. The frequency of G allele was higher in patients (78%) than in controls (70.5 %) (OR=1.48, 95% CI=1.01-2.20, P=0.04). Conclusions: The high G allele and G/G genotype frequency in patients compared to control subjects suggests that the IL-6 -174 G/C polymorphism may influence the susceptibility to gastric cancer. In addition, the demographic information showed that most of the subjects were male (69.0%) that gastric cancer is related to environmental factors.

Citing Articles

The Effect of IL-6 174G > C Gene Polymorphism on Gastrointestinal Cancer: a Systematic Review and Meta-analysis.

Darvishi N, Salari N, Bokaee S, Shohaimi S, Mohammadi M Indian J Surg Oncol. 2023; 14(2):411-422.

PMID: 37324283 PMC: 10267097. DOI: 10.1007/s13193-022-01698-1.


Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk.

Harun-Or-Roshid M, Ali M, Jesmin , Haque Mollah M PLoS One. 2021; 16(3):e0247055.

PMID: 33684135 PMC: 7939379. DOI: 10.1371/journal.pone.0247055.


Thrombocytopenia in solid tumors: Prognostic significance.

Ghanavat M, Ebrahimi M, Rafieemehr H, Maniati M, Maleki Behzad M, Shahrabi S Oncol Rev. 2019; 13(1):413.

PMID: 31205603 PMC: 6542370. DOI: 10.4081/oncol.2019.413.

References
1.
Shamsabadi F, Akbari Eidgahi M, Mehrbod P, Daneshvar N, Allaudin Z, Yamchi A . Survivin, a Promising Gene for Targeted Cancer Treatment. Asian Pac J Cancer Prev. 2016; 17(8):3711-9. View

2.
Mantovani G, Maccio A, Madeddu C, Mura L, Gramignano G, Lusso M . Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer. 2002; 98(1):84-91. DOI: 10.1002/ijc.10143. View

3.
Mansoori M, Golalipour M, Alizadeh S, Jahangirerad A, Khandozi S, Fakharai H . Genetic Variation in the ABCB1 Gene May Lead to mRNA Level Chabge: Application to Gastric Cancer Cases. Asian Pac J Cancer Prev. 2016; 16(18):8467-71. DOI: 10.7314/apjcp.2015.16.18.8467. View

4.
Terry C, Loukaci V, Green F . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000; 275(24):18138-44. DOI: 10.1074/jbc.M000379200. View

5.
Fernandez-Real J, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M . Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes. 2000; 49(3):517-20. DOI: 10.2337/diabetes.49.3.517. View